Abcellera Biologics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $7,323 | $9,954 | $9,179 | $6,599 |
Gross Profit | -30,714 | 3,188 | 70 | -810 |
EBITDA | -55,417 | -48,128 | -53,568 | -44,653 |
EBIT | -93,454 | -54,894 | -62,677 | -52,062 |
Net Income | -36,930 | -40,610 | -47,150 | -28,610 |
Net Change In Cash | 7,323 | 9,954 | 9,179 | 6,599 |
Free Cash Flow | -49,255 | -65,848 | -34,042 | -20,997 |
Cash | 173,312 | 148,572 | 133,320 | 172,422 |
Basic Shares | 294,217 | 292,723 | 290,046 | 289,496 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $38,025 | $485,424 | $11,611 | $233,155 |
Gross Profit | 7,131 | 418,988 | 11,611 | 206,012 |
EBITDA | -192,158 | 276,246 | -154 | 169,915 |
EBIT | -223,052 | 243,144 | -2,001 | 164,644 |
Net Income | -146,398 | 158,519 | -2,210 | 118,918 |
Net Change In Cash | 38,025 | 485,424 | 11,611 | 233,155 |
Cost of Revenue | -76,893 | -91,549 | ||
Free Cash Flow | -121,384 | 204,700 | 186,132 | 8,017 |
Cash | 133,320 | 386,535 | 476,142 | 594,116 |
Basic Shares | 289,166 | 314,827 | 318,294 | 269,497 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.13 |
2024-03-31 | -$0.14 |
2023-12-31 | -$0.17 |
2023-09-30 | -$0.10 |
